Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of ...

Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.

FDA authorizes an expanded access treatment protocol after the oral RAS(ON) inhibitor doubled survival for metastatic patients in a phase 3 trial.

A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...

Using a more pragmatic classification system than the current standard provided clearer discrimination between disease ...

Wheat allergy in young children is uncommon, but many referred children tolerate wheat protein or have a reaction only to ...

The largest US study to date on teen cannabis uses shows that cannabis use during adolescence may hinder cognitive improvement over time.

To have a drug that has an impact on mortality, it’s of huge interest and a benefit for patients with ILD,’ said rheumatologist Voon Ong, MBBS, PhD, who was not involved in the study.

A study from a single medical center in California has observed a nearly 15% prevalence of methamphetamine use in patients presenting with acute coronary syndrome.

Recent data from a single-arm trial suggest favorable-risk patients with HPV-associated oropharyngeal carcinoma may benefit from a deintensified regimen.

The US FDA has proposed an end to most types of compounding of semaglutide, tirzepatide, and liraglutide. The agency said in a statement it has determined there is no longer a clinical need for ...

Multiple intramolecular switches among anti-TNF agents in children with inflammatory bowel disease show no clinically ...